News · NuScale Power Corporation (SMR) · Industrials
NuScale Power rises 4.4% as investors note upcoming earnings call and ENTRA1 coverage
What happened
NuScale Power (SMR) rose 4.4% on October 6, 2026, as investors focused on a scheduled Q3 earnings call and coverage of its ENTRA1 partnership. The stock closed at $8.02 after opening 4.0% above the previous close and traded at 1.2 times its 20-day average volume. News around the company included a Business Wire notice that NuScale scheduled its third quarter 2026 earnings conference call for Thursday, November 5, 2026, at 5:00 p.m. ET, and a Zacks Investment Research article discussing the ENTRA1 partnership and potential commercial nuclear deployments with customers such as TVA, data centers and industrial users.
How big was the move
The stock rose 4.4% on the session, a change that was 0.8 times a typical daily move for this stock and 4.1 percentage points better than the Industrials sector median on the day. The S&P 500 rose 0.6% on the same day and rose 1.9% over five sessions; NuScale rose 3.4% over the last five sessions. Trading volume ran at 1.2 times its 20-day average, signaling above-normal activity. With a beta of 3.33, the stock tends to move more than the market, which helps explain why routine corporate developments such as an earnings call and analyst coverage can coincide with outsized daily swings.
Viewed in isolation, the daily move was ordinary for this stock. It outpaced the sector on the day but did not represent an extreme technical event. The comparison with the Industrials sector median helps frame the session: market participants gave NuScale more attention than its peers, but the stock’s volatility and high beta mean similar sessions are common.
The technical picture
Technically, the stock sat below its short-, medium- and long-term averages. It was 5.8% below its 20-day moving average, 10.8% below its 50-day moving average and 32.4% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) was 43, in a neutral range between 30 and 70. Recent price action showed a one-month decline of 17.3% and a three-month decline of 8.4%.
Over one year the stock fell 80.0% and was 96.4 percentage points behind the S&P 500. Distance from the 52-week high stood at 86.0% below that high. Volatility measured 89% annualized over 60 days, lower than 56% of its own readings over five years. Those readings combine a clear downtrend with episodic spikes in trading that are consistent with a high-beta name in a cyclical sector.
Fundamentals and valuation
For the four quarters through June 30, 2026, the company reported revenue of $10.7 million, a decline of 81.0% from a year earlier and a decline of 61.9% from one quarter earlier. Diluted earnings per share for that period were $-2.57 and gross margin was 21.1%, down from 71.5% a year earlier. The data show an operating margin of 6854.0%, a free-cash-flow margin of 7267.3% and return on invested capital of 36.3%. The balance sheet showed net cash of $760.5 million, and share count over one year increased by 22.7%. On valuation metrics the free-cash-flow yield is 33.6%.
Those fundamentals present a mixed and somewhat contradictory picture. Top-line revenue and gross margin contracted sharply, suggesting pressure on core operations. At the same time, the company reported very large operating and free-cash-flow margins and held meaningful net cash, which provide a cushion for near-term funding needs and support valuation measures such as the free-cash-flow yield. The increase in share count over one year points to dilution that can weigh on per-share metrics even as cash metrics look favorable.
Earnings and analyst expectations
NuScale scheduled its next report for November 5, 2026, with an earnings conference call set for 5:00 p.m. ET. The last report, on August 5, 2026, showed earnings per share of $-0.13 against $-0.13 expected, 0.2% above estimates. The stock has recorded one consecutive quarter beating estimates, and the average surprise over the last four reports is 100.0% below estimates. The typical two-day reaction after recent reports has been that the stock fell 3.9%.
Analysts place a consensus price target of $11.25, which is 40.3% above the closing price. Sixteen analysts provide ratings, with 50% of the ratings at Buy and a consensus rating of Buy. PromtFinance scores rank the company weakly across several dimensions within the sector: Value 1, Growth 18, Quality 1, Momentum 4, Revisions 23 and Stability 2.
The combination of a consensus price target above the current price and weak PromtFinance scores reflects a split view: analysts appear to see upside potential, while fundamental scores point to weakness on multiple dimensions. Investors looking ahead to the November report will weigh that mix as they assess whether recent coverage and the ENTRA1 discussion can translate into visible commercial progress.
What to watch
- Next report: November 5, 2026 (scheduled earnings conference call at 5:00 p.m. ET).
- Market value: $2.31 billion.
- Consensus price target: $11.25, 40.3% above the closing price.
- Business Wire: announcement of the Q3 2026 earnings conference call.
- Zacks Investment Research: coverage of the ENTRA1 partnership and potential commercial deployments.